CorMedix Inc (NASDAQ: CRMD) is 61.44% higher on its value in year-to-date trading and has touched a low of $2.57 and a high of $7.00 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CRMD stock was last observed hovering at around $6.02 in the last trading session, with the day’s gains setting it 0.05%.
Currently trading at $6.07, the stock is 27.94% and 31.97% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.51 million and changing 0.83% at the moment leaves the stock 43.28% off its SMA200. CRMD registered 47.69% gain for a year compared to 6-month gain of 71.47%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 32.53% loss in the last 1 month and extending the period to 3 months gives it a 14.96%, and is 19.02% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.49% over the week and 8.12% over the month.
CorMedix Inc (CRMD) has around 82 employees, a market worth around $339.07M and $0.81M in sales. Fwd P/E is 151.75. Profit margin for the company is -6589.10%. Distance from 52-week low is 136.19% and -13.29% from its 52-week high. The company has generated returns on investments over the last 12 months (-113.94%).
The EPS is expected to grow by 31.43% this year
124.0 institutions hold shares in CorMedix Inc (CRMD), with institutional investors hold 31.10% of the company’s shares. The shares outstanding are 54.94M, and float is at 54.83M with Short Float at 18.82%. Institutions hold 30.81% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 3.55 million shares valued at $15.39 million. The investor’s holdings represent 6.1796 of the CRMD Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 2.9 million shares valued at $12.57 million to account for 5.0476 of the shares outstanding. The other top investors are ELLIOTT INVESTMENT MANAGEMENT L.P. which holds 1.55 million shares representing 2.6964 and valued at over $6.71 million, while NOMURA HOLDINGS INC holds 2.4733 of the shares totaling 1.42 million with a market value of $6.16 million.
CorMedix Inc (CRMD) Insider Activity
The most recent transaction is an insider purchase by Todisco Joseph, the company’s Chief Executive Officer. SEC filings show that Todisco Joseph bought 13,561 shares of the company’s common stock on Mar 13 ’24 at a price of $3.74 per share for a total of $50718.0. Following the purchase, the insider now owns 0.35 million shares.
CorMedix Inc disclosed in a document filed with the SEC on Dec 14 ’23 that DUNTON ALAN W (Director) bought a total of 3,000 shares of the company’s common stock. The trade occurred on Dec 14 ’23 and was made at $3.45 per share for $10350.0. Following the transaction, the insider now directly holds 12250.0 shares of the CRMD stock.
Still, SEC filings show that on Dec 15 ’23, DUNTON ALAN W (Director) acquired 3,000 shares at an average price of $3.30 for $9900.0. The insider now directly holds 15,250 shares of CorMedix Inc (CRMD).
